Medscape | Topical Tacrolimus 0.03% as Sole Therapy in Vernal Keratoconjunctivitis Medscape Recent clinical trials have also shown that, like corticosteroids, tacrolimus and other immunosuppressive drugs have similar efficacy in allergic crisis control and maintenance therapy for VKC but with a low incidence of side effects. In addition to ... |
